Glucose Transporter Type 1 Deficiency Syndrome Clinical Trial
Official title:
Post Study Continuation of C7 for G1D
This protocol provides ongoing access to triheptanoin for patients who did complete an initial pilot protocol, and provides the opportunity to collect long-term safety data from patients treated with triheptanoin.
Only patients who completed the initial pilot study were eligible. The study is ongoing with these patients only. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT02599961 -
Study to Assess the Long Term Safety and Efficacy of UX007 in Participants With Glucose Type 1 Deficiency Syndrome (Glut1 DS)
|
Phase 2 | |
| Enrolling by invitation |
NCT03655223 -
Early Check: Expanded Screening in Newborns
|
||
| Recruiting |
NCT05085704 -
Brain Metabolism Observed at 7 Tesla
|
||
| Withdrawn |
NCT03202108 -
Evaluation of Krio in Children and Adults With Epilepsy
|
N/A | |
| Active, not recruiting |
NCT04137692 -
Red Blood Cell Exchange Transfusion as a Novel Treatment for GLUT1 Deficiency Syndrome
|
N/A | |
| Completed |
NCT03041363 -
Treatment Development of Triheptanoin (G1D)
|
Phase 1 | |
| Completed |
NCT02018315 -
Treatment Development for Glucose Transporter Type I Deficiency Syndrome (G1D)
|
Phase 1 | |
| Completed |
NCT04399954 -
Evaluation of Ketoflo
|
N/A | |
| Withdrawn |
NCT02021526 -
Triheptanoin (C7 Oil), a Food Supplement, for Glucose Transporter Type I Deficiency (G1D)
|
Phase 1/Phase 2 | |
| Recruiting |
NCT02013583 -
The Glucose Transporter Type I Deficiency (G1D) Registry
|
||
| Completed |
NCT02915211 -
Evaluation of Keyo in Children With Epilepsy
|
N/A | |
| Active, not recruiting |
NCT02000960 -
Pilot Study of Triheptanoin in Patients With Glucose Transporter 1 Deficiency Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT03181399 -
Diet Treatment Glucose Transporter Type 1 Deficiency (G1D)
|
Phase 2 |